![](/us.svg)
Trademark: 97094701
Status Date
Friday, February 16, 2024
Filing Date
Wednesday, October 27, 2021
Published for Opposition
Tuesday, February 15, 2022
5 pharmaceutical preparations for use in the treatment of seizures, bipolar disorders, depression and neurofibromatosis; pharmaceutical preparations for the prevention and treatment of central nervous system disorders, neurological diseases and disorders, neurodegenerative disorders, and depression
Feb 17, 2024
Notice Of Approval Of Extension Request E-Mailed
Feb 16, 2024
Sou Extension 4 Granted
Feb 16, 2024
Sou Extension 4 Filed
Feb 16, 2024
Sou Teas Extension Received
Aug 25, 2023
Notice Of Approval Of Extension Request E-Mailed
Aug 23, 2023
Sou Extension 3 Granted
Aug 23, 2023
Sou Extension 3 Filed
Aug 23, 2023
Sou Teas Extension Received
Mar 17, 2023
Notice Of Approval Of Extension Request E-Mailed
Mar 15, 2023
Sou Extension 2 Granted
Mar 15, 2023
Sou Extension 2 Filed
Mar 15, 2023
Sou Teas Extension Received
Aug 27, 2022
Notice Of Approval Of Extension Request E-Mailed
Aug 25, 2022
Sou Extension 1 Granted
Aug 25, 2022
Sou Extension 1 Filed
Aug 25, 2022
Sou Teas Extension Received
Apr 12, 2022
Noa E-Mailed - Sou Required From Applicant
Feb 15, 2022
Official Gazette Publication Confirmation E-Mailed
Feb 15, 2022
Published For Opposition
Jan 26, 2022
Notification Of Notice Of Publication E-Mailed
Jan 10, 2022
Approved For Pub - Principal Register
Jan 7, 2022
Assigned To Examiner
Nov 9, 2021
New Application Office Supplied Data Entered
Trademark Alertz updated from USPTO on 2030-01-24